Dynamic Contrast-Enhanced US for monitoring of anti-angiogenic treatments

Following the recent development of targeted therapies, more patients are now eligible for antiangiogenic treatments. Conventional techniques to assess efficacy of these treatments, with morphological imaging are unsuitable; since antiangiogenic treatments induce lesion necrosis without modification of the initial tumor size.